Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1600-1603

  Lee, Jong Hwa ^a,b   Shin, Ji Hyun ^a   Roe, Im Hwan ^a   Sohn, Seung Ghyu ^b   Lee, Jung Hun ^b   Kang, Geun Ho ^b   Lee, Han Ki ^b   Jeong, Byeong Chul ^b   Lee, Sang Hee ^b  

^a Dankook University College of Medicine   (South Korea)

^b Myong Ji University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CAGA PROTEIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RIBOSOME RNA;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONSENSUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA SEQUENCE; DRUG CHOICE; DRUG EFFECT; DYSPEPSIA; ERADICATION THERAPY; EVALUATION; FEMALE; GENE EXPRESSION; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH BIOPSY;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, RRNA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; PEPTIC ULCER; RNA, RIBOSOMAL, 23S; TREATMENT OUTCOME;

EID: 16244376149     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1600-1603.2005     Document Type: Article

References (23)

1. Debets-Ossenknopp, Y. J., A. J. Herscheid, R. G. Pot, E. J. Kuipers, J. G. Kusters, and C. M. Vandenbroucke-Grauls. 1999. Prevalence of Helicobaaer pylori resistance to metronidazole, clarithromydn, amoxicillin, tetracycline, and trovafloxacin in The Netherlands. J. Antimicrob. Chemother. 43:511-515.
2. Dore, M. P., G. Leandro, G. Realdi, A. R. Sepulveda, and D. Y. Graham. 2000. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy. Dig. Dis. Sci. 45:68-76.
3. Drumm, B. S., S. Koletzko, and G. Oderda, on behalf of the European Pediatric Task Force on Helicobacter pylori. 2001. Helicobaaer pylori infection in children: a consensus statement. J. Pediatr. Gastroenterol. Nutr. 30:207-213.
4. Fontana, C., M. Favaro, S. Minelli, A. A. Criscuolo, A. Pietroiusti, A. Galante, and C. Favalli. 2002. New site of modification of 23S rRNA associated with darithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob. Agents Chemother. 46:3765-3769.
5. Graham, D. Y., and W. A. Qureshi. 2000. Antibiotic-resistant H. pylori infection and its treatment. Curr. Pharm. Des. 15:1537-1544.
6. Kalach, N., P. H. Benhamou, F. Campeotto, M. Bergeret, C. Doupont, and J. Raymond. 2001. Clarithromycin resistance and eradication of Helicobacter pylori in children. Antimicrob. Agents Chemother. 45:2134-2135.
7. Khan, R., S. Nahar, J. Sultana, M. M. Ahmad, and M. Rahman. 2004. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob. Agents Chemother. 48:3567-3569.
8. Kim, J. H., H. Y. Kim, N. Y. Kim, S. W. Kim, J. G. Kim, J. J. Kim J. K. Seo, J. G. Sim, I. H. Roe, H. S. Ahn, B. C. Yoon, S. W. Lee, Y. C. Lee, I. S. Chung, H. Y. Jung, W. S. Hong, and K. W. Choi. 2000. Seroprevalence of Helicobacter pylori infection in asymptomatic people in Korea. Kor. J. Med. 59:388-397.
9. Mikula, M., A. Dzwonek, K. Jagusztyn-Krynicka, and J. Ostrowski. 2003. Quantitative detection for low levels of Helicobacter pylori infection in experimentally infected mice by real-time PCR. J. Microbiol. Methods 55:351-359.
10. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing. Ninth informational supplement M100-S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. 1994. Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69.
12. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
13. Pilotto, A., M. Rassu, G. Leandro, M. Franceschi, and F. Di Mario. 2000. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. Dig. Liver Dis. 32:763-768.
14. Raymond, J., N. Kalach, M. Bergeret, P. H. Benhamou, J. P. Barbet, D. Gendrel, and C. Dupont. 1998. Effect of metronidazole resistance on bacterial eradication of Helicobacier pylori in infected children. Antimicrob. Agents Chemother. 42:1334-1335.
15. Taylor, D. E., M. Eaton, N. Chang, and S. M. Salama. 1992. Construction of Helicobacter pylori genome map and demonstration of diversity at the genome level. J. Bacteriol. 174:6800-6806.
16. Toracchio, S., G. M. Aceto, R. Mariani-Costantini, P. Battista, and L. Marzio. 2004. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori. Helicobacter 9:396-399.
17. Toracchio, S., L. Cellini, D. I. Campli, G. Cappello, M. G. Malatesta, A. Ferri, A. F. Ciccaglione, L. Grossi, and L. Marzio. 2000. Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. Aliment. Pharmacol. Ther. 14:1639-1643.
18. Toracchio, S., and L. Marzio. 2003. Primary and secondary antibiotic resistance of Helicobacter pylori strains in central Italy during the years 1998-2002. Dig. Liver Dis. 35:541-545.
19. Tucci, A., O. Varoli, R. Corinaldesi, V. Stanghellini, S. Gasperoni, G. F. Paparo, M. Ricci-Maccarini, M. La Placa, and L. Barbara. 1993. Evaluation of Helicobacter pylori sensitivity to amoxicillin and metronidazole in dyspeptic patients. Ital. J. Gastroenterol. 25:65-67.
20. van Doorn, L.-J., Y. Glupczinski, J. G. Kusters, F. Mégraud, P. Midolo, N. Maggi-Solcà, D. M. M. Queiroz, N. Nouhan, E. Stet, and W. G. V. Quint. 2001. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob. Agents Chemother. 45:1500-1504.
21. Warren, J. R., and B. J. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet i:1273-1275.
22. Wolle, K., M. Nilius, A. Leodolter, W. A. Muller, P. Malfertheiner, and W. Koning. 1998. Prevalence of Helicobacter pylori resistance to several antimicrobial agents in a region of Germany. Eur. J. Clin. Microbiol. Infect. Dis. 17:519-521.
23. Xiang, Z., S. Censini, P. F. Bsyeli, Y. Chang, J. H. Vogelman, N. Orentrich, and R. K. Sibley. 1995. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:94-98.